Atherosclerosis is the thickening and loss of elasticity of the walls of arteries that is associated with the formation of atherosclerotic plaques within the arterial intima. Inflammation has an ...

Dyslipidemia is a major risk factor contributing ... a process that is central to the pathogenesis of atherosclerosis. In ART-naive patients, the proinflammatory state may contribute to mortality ...

HIV-related dyslipidemia and insulin resistance are ... resistance based on fasting blood glucose and insulin levels. This Nature Research Intelligence Topic summary is one of 30,000 created ...

Their work was published in Nature Cardiovascular Research. Atherosclerotic cardiovascular disease (ASCVD) caused by atherosclerosis is one of the leading causes of death worldwide. Inflammation ...

Dyslipidemia refers to lipoprotein disorders ... as parents or grandparents aged 55 years or younger with evidence of atherosclerosis, peripheral vascular disease, cerebrovascular disease, or ...

Sugar-sweetened beverages (SSBs) are a ubiquitous part of diets worldwide, yet their toll on public health is staggering.

PCSK9 is implicated in various processes such as lipid metabolism, atherosclerosis, oxidative stress, inflammatory responses, thrombosis, and apoptosis. It is closely linked to ischemic stroke through ...

Jan. 29, 2025 — Researchers have identified priority areas for conserving the black-tailed prairie dog in the United States. Protecting these regions will also benefit North America's Central ...

Ley has received research funding for developing an atherosclerosis vaccine formulation from United Bioscience, Inc. The other author reports no conflicts. This work was supported by grants to D. Wolf ...

Solbinsiran sodium is under clinical development by Eli Lilly and Co and currently in Phase II for Mixed Dyslipidemia. According to GlobalData, Phase II drugs for Mixed Dyslipidemia have a 74% phase ...